Relapsing Forms of Multiple Sclerosis Withdrawn Phase 3 Trials for Dimethyl fumarate (DB08908)

IndicationStatusPhase
DBCOND0036449 (Relapsing Forms of Multiple Sclerosis)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02428218Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)Treatment